Edge Wealth Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-20,000
| Closed | -$63K | – | 594 |
|
|
2019
Q3 | $63K | Sell |
20,000
-10,000
| -33% | -$31.5K | 0.01% | 226 |
|
|
2019
Q2 | $101K | Hold |
30,000
| – | – | 0.02% | 195 |
|
|
2019
Q1 | $91K | Buy |
30,000
+20,000
| +200% | +$60.7K | 0.02% | 189 |
|
|
2018
Q4 | $16K | Hold |
10,000
| – | – | ﹤0.01% | 348 |
|
|
2018
Q3 | $27K | Hold |
10,000
| – | – | 0.01% | 324 |
|
|
2018
Q2 | $26K | Sell |
10,000
-40,000
| -80% | -$104K | 0.01% | 322 |
|
|
2018
Q1 | $138K | Hold |
50,000
| – | – | 0.04% | 145 |
|
|
2017
Q4 | $162K | Hold |
50,000
| – | – | 0.05% | 140 |
|
|
2017
Q3 | $209K | Sell |
50,000
-10,000
| -17% | -$41.8K | 0.06% | 125 |
|
|
2017
Q2 | $331K | Buy |
60,000
+20,000
| +50% | +$110K | 0.1% | 101 |
|
|
2017
Q1 | $230K | Buy |
+40,000
| New | +$230K | 0.08% | 116 |
|